Ablation should be 1st line therapy in the high risk Brugada Syndrome patient - CON
20 March 2018 (08:47 - 09:00)
Organised by:
Slides
About the speaker
Tel Aviv Sourasky Medical Center, Tel Aviv (Israel)
11 More presentations in this session
Professor V. Probst (Nantes, FR)
Access the full session
The Event
EHRA 2018
20 March 2018
08:47 CET
